Will the sins of its child be visited on Dow Chemical? On Nov. 14, the chemical giant will stand trial with Dow Corning, its 50%-owned subsidiary, in two key liability suits involving silicone breast implants. A Texas judge on Oct. 31 refused to dismiss Dow Chemical from the suits, ruling that it could be held liable if it knew of the dangers of silicone. Investors dragged Dow Chemical's stock down 8.5% by Nov. 4, worried not only about the Houston

cases--and 1,000 others in Texas--but also by the possibility that Dow's deep pockets will encourage more suits.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE